Triangle Securities Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $680K | Buy |
|
|||||
|
2025
Q2 | $769K | Buy |
|
|||||
|
2025
Q1 | $833K | Sell |
|
|||||
|
2024
Q4 | $711K | Sell |
|
|||||
|
2024
Q3 | $830K | Sell |
|
|||||
|
2024
Q2 | $858K | Sell |
|
|||||
|
2024
Q1 | $773K | Sell |
|
|||||
|
2023
Q4 | $770K | Sell |
|
|||||
|
2023
Q3 | $692K | Sell |
|
|||||
|
2023
Q2 | $757K | Sell |
|
|||||
|
2023
Q1 | $740K | Sell |
|
|||||
|
2022
Q4 | $695K | Sell |
|
|||||
|
2022
Q3 | $828K | Sell |
|
|||||
|
2022
Q2 | $863K | Buy |
|
|||||
|
2022
Q1 | $754K | Sell |
|
|||||
|
2021
Q4 | $691K | Buy |
|
|||||
|
2021
Q3 | $547K | Buy |
|
|||||
|
2021
Q2 | $522K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $68K | Buy |
|